Drugs / hP1A8
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04642937 | Dec 2020 → Nov 2023 | glioblastoma | OX2 Therapeutics | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hP1A8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04642937 ↗ |